JOSÉ LUIS
LOBO BERISTAIN
Forscher bis um 2023
Hospital Universitari de Tarragona Joan XXIII
Tarragona, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitari de Tarragona Joan XXIII (3)
2022
-
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
Research and Practice in Thrombosis and Haemostasis, Vol. 6, Núm. 4
2019
-
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
Scientific Reports, Vol. 9, Núm. 1
2018
-
Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants
Clinical Pharmacology and Therapeutics, Vol. 103, Núm. 4, pp. 684-691